Skip to content
10-Q

Quarterly Report

PEAK PHARMACEUTICALS, INC. RMHI

0001199835-22-000836

← back to feed
Filed
Dec 19, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2022 · Jun 30, 2022 82M sh
Operating Cash Flow Q3 2022 · Jun 30, 2022 −$64.81K
Stockholders Equity Q3 2022 · Jun 30, 2022 −$431.27K
Stockholders Equity Q3 2022 · Mar 31, 2022 −$440.1K
Stockholders Equity Q3 2022 · Dec 31, 2021 −$385.54K
Stockholders Equity Q3 2022 · Sep 30, 2021 −$326.19K
Stockholders Equity Q3 2022 · Jun 30, 2021 −$319.37K
Stockholders Equity restated Q3 2022 · Mar 31, 2021 −$5.16M
Stockholders Equity Q3 2022 · Dec 31, 2020 −$257.45K
Total Liabilities Q3 2022 · Jun 30, 2022 $565.36K
Total Liabilities Q3 2022 · Sep 30, 2021 $587.34K
Total Assets Q3 2022 · Jun 30, 2022 $134.09K
Total Assets Q3 2022 · Sep 30, 2021 $261.15K
Eps Diluted Q3 2022 · Jun 30, 2022 $0.00
Eps Basic Q3 2022 · Jun 30, 2022 $0.00
Eps Basic Q3 2022 · Jun 30, 2021 $0.00
Eps Basic Q3 2022 · Jun 30, 2021 $0.00
Net Income Q3 2022 · Jun 30, 2022 $8.83K
Net Income Q3 2022 · Jun 30, 2022 −$105.09K
Net Income Q3 2022 · Mar 31, 2022 −$54.56K
Net Income Q3 2022 · Dec 31, 2021 −$59.36K
Net Income Q3 2022 · Jun 30, 2021 −$19.21K
Net Income Q3 2022 · Mar 31, 2021 −$42.71K
Net Income Q3 2022 · Dec 31, 2020 −$7.35K
Operating Income Q3 2022 · Jun 30, 2022 −$12.09K
Operating Income Q3 2022 · Jun 30, 2022 −$110.72K
Operating Income Q3 2022 · Jun 30, 2021 −$16.85K